MX6887A - Procedimiento para la preparacion de compuestos analogos de ergolina. - Google Patents
Procedimiento para la preparacion de compuestos analogos de ergolina.Info
- Publication number
- MX6887A MX6887A MX688787A MX688787A MX6887A MX 6887 A MX6887 A MX 6887A MX 688787 A MX688787 A MX 688787A MX 688787 A MX688787 A MX 688787A MX 6887 A MX6887 A MX 6887A
- Authority
- MX
- Mexico
- Prior art keywords
- analog
- procedure
- preparation
- ergoline compounds
- ergoline
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D457/00—Heterocyclic compounds containing indolo [4, 3-f, g] quinoline ring systems, e.g. derivatives of ergoline, of the formula:, e.g. lysergic acid
- C07D457/04—Heterocyclic compounds containing indolo [4, 3-f, g] quinoline ring systems, e.g. derivatives of ergoline, of the formula:, e.g. lysergic acid with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached in position 8
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
- C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
- C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D215/20—Oxygen atoms
- C07D215/22—Oxygen atoms attached in position 2 or 4
- C07D215/233—Oxygen atoms attached in position 2 or 4 only one oxygen atom which is attached in position 4
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/14—Drugs for genital or sexual disorders; Contraceptives for lactation disorders, e.g. galactorrhoea
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
- C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
- C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D215/20—Oxygen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
- C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
- C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D215/38—Nitrogen atoms
- C07D215/42—Nitrogen atoms attached in position 4
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
- C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
- C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D215/48—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
- C07D215/54—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen attached in position 3
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
- C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
- C07D491/10—Spiro-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D513/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00
- C07D513/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00 in which the condensed system contains two hetero rings
- C07D513/04—Ortho-condensed systems
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Health & Medical Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Biomedical Technology (AREA)
- Hospice & Palliative Care (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Psychiatry (AREA)
- Gynecology & Obstetrics (AREA)
- Pregnancy & Childbirth (AREA)
- Endocrinology (AREA)
- Reproductive Health (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
- Quinoline Compounds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US06/874,741 US4826986A (en) | 1986-06-16 | 1986-06-16 | 6-Oxo-trans-octa- and decahydroquinolines |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| MX6887A true MX6887A (es) | 1993-11-01 |
Family
ID=25364464
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MX688787A MX6887A (es) | 1986-06-16 | 1987-06-11 | Procedimiento para la preparacion de compuestos analogos de ergolina. |
Country Status (16)
| Country | Link |
|---|---|
| US (1) | US4826986A (es) |
| EP (1) | EP0250179A3 (es) |
| JP (1) | JPS62298589A (es) |
| KR (1) | KR890005302B1 (es) |
| CN (1) | CN1016872B (es) |
| AT (1) | AT390061B (es) |
| AU (1) | AU597073B2 (es) |
| CA (1) | CA1307526C (es) |
| DK (1) | DK299787A (es) |
| HU (1) | HU197900B (es) |
| MX (1) | MX6887A (es) |
| NZ (1) | NZ220650A (es) |
| PH (1) | PH25132A (es) |
| PT (1) | PT85061B (es) |
| SU (1) | SU1644718A3 (es) |
| ZA (1) | ZA874137B (es) |
Families Citing this family (18)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| SU1421258A3 (ru) * | 1984-08-02 | 1988-08-30 | Эли Лилли Энд Компани (Фирма) | Способ получени транс-октагидрооксазоло(4,5 @ )хинолина или его фармацевтически приемлемых солей |
| US5134143A (en) * | 1986-06-16 | 1992-07-28 | Eli Lilly And Company | BCD tricyclic ergoline part-structure analogues |
| US4977160A (en) * | 1986-06-16 | 1990-12-11 | Eli Lilly And Company | BCD tricyclic ergoline part-structure analogues |
| US4743607A (en) * | 1987-05-29 | 1988-05-10 | Merrell Dow Pharmaceuticals Inc. | Cardiotonic tricyclic imidazolones |
| US4977149A (en) * | 1989-07-24 | 1990-12-11 | Eli Lilly And Company | Pyridoquinoline dopamine agonists, compositions and use |
| US5057515A (en) * | 1989-07-24 | 1991-10-15 | Eli Lilly And Company | Method for agonizing a dopamine receptor |
| US4939259A (en) * | 1989-07-24 | 1990-07-03 | Eli Lilly And Company | 2-oxo-pyrido[2,3-g]quinoline derivatives |
| US5436344A (en) * | 1990-11-29 | 1995-07-25 | Pfizer Inc. | 3-bromo-5-chloro-pyridines used as intermediates in the synthesis of azatetralones |
| US5416090A (en) * | 1991-01-31 | 1995-05-16 | Eli Lilly And Company | Method of treating inflammation |
| US6835841B2 (en) | 2002-09-13 | 2004-12-28 | Bristol-Myers Squibb Company | Asymmetric catalytic hydrogenation process for preparation of chiral cyclic β-aminoesters |
| SG149829A1 (en) | 2003-10-03 | 2009-02-27 | 3M Innovative Properties Co | Pyrazolopyridines and analogs thereof |
| US7544697B2 (en) * | 2003-10-03 | 2009-06-09 | Coley Pharmaceutical Group, Inc. | Pyrazolopyridines and analogs thereof |
| TWI537274B (zh) | 2011-03-14 | 2016-06-11 | 橘生藥品工業股份有限公司 | 新穎之八氫噻吩并喹啉衍生物、含有其之醫藥組成物及該等之用途 |
| JP6177061B2 (ja) * | 2012-09-12 | 2017-08-09 | キッセイ薬品工業株式会社 | 新規なドパミンｄ２受容体アゴニスト |
| JP6166990B2 (ja) * | 2012-09-12 | 2017-07-19 | キッセイ薬品工業株式会社 | オクタヒドロチエノキノリン誘導体の製造方法及びその製造中間体 |
| JP6242811B2 (ja) * | 2012-12-10 | 2017-12-06 | キッセイ薬品工業株式会社 | 新規なオクタヒドロピリドキナゾリン誘導体、それを含有する医薬組成物およびそれらの用途 |
| WO2014112492A1 (ja) * | 2013-01-17 | 2014-07-24 | キッセイ薬品工業株式会社 | 新規なオクタヒドロキノリン誘導体、それを含有する医薬組成物およびそれらの用途 |
| KR102084044B1 (ko) * | 2018-12-24 | 2020-03-03 | 주식회사 세미부스터 | 인산용액 중의 실리콘 농도 분석방법 |
Family Cites Families (19)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4198415A (en) * | 1979-01-22 | 1980-04-15 | Eli Lilly And Company | Prolactin inhibiting octahydro pyrazolo[3,4-g]quinolines |
| US4235909A (en) * | 1979-04-19 | 1980-11-25 | Eli Lilly And Company | Octahydro-2H-pyrrolo[3,4-g]quinolines |
| US4230861A (en) * | 1979-01-22 | 1980-10-28 | Eli Lilly And Company | 1-And/or 7-substituted-6-hydroxy (or oxo)-3-decahydroquinoline carboxylic acids |
| JPS55120566A (en) * | 1979-03-09 | 1980-09-17 | Mitsui Toatsu Chem Inc | New quinoline derivative |
| US4471121A (en) * | 1982-11-03 | 1984-09-11 | Eli Lilly And Company | Method of resolving trans-d alpha-1-n-propyl-6-oxodecahydroquinoline and di-p-toluoyltartaric acid salts thereof |
| ES524453A0 (es) * | 1982-11-03 | 1984-12-01 | Lilly Co Eli | Un procedimiento para la obtencion de un tautomero de pirazoloquinolinas |
| US4567266A (en) * | 1982-11-03 | 1986-01-28 | Eli Lilly And Company | Method of preparing octahydro-1H(and 2H)-pyrazolo[3,4-g]quinolines |
| US4647667A (en) * | 1982-11-03 | 1987-03-03 | Eli Lilly And Company | Octa- and deca-hydroquinoline intermediates |
| AU546346B2 (en) * | 1983-01-11 | 1985-08-29 | Eli Lilly And Company | 1,3 disubstituted-6 oxo-decahydro quinolines |
| US4528290A (en) * | 1984-01-30 | 1985-07-09 | Eli Lilly And Company | Stimulating dopamine D-1 receptors |
| IL73001A0 (en) * | 1983-09-26 | 1984-12-31 | Lilly Co Eli | Improvements in and relating to 6-oxodecahydroquinolines |
| US4507478A (en) * | 1983-09-26 | 1985-03-26 | Eli Lilly And Company | 2-Mercaptopyrimidohexahydroquinolines and related compounds |
| IL72730A (en) * | 1983-09-26 | 1987-10-30 | Lilly Co Eli | Octahydro-2-pyrimido(4,5-g)quinolinamines,their preparation and pharmaceutical compositions containing them |
| US4778894A (en) * | 1983-09-26 | 1988-10-18 | Eli Lilly And Company | 6 oxo-decahydroquinolines |
| US4501890A (en) * | 1983-09-26 | 1985-02-26 | Eli Lilly And Company | Trans-(±)-2,4,6-substituted-5,5a,6,7,8,9,9a,10-octahydro-pyrimido[4,5-g]quinolines |
| US4537893A (en) * | 1984-04-27 | 1985-08-27 | Eli Lilly And Company | Octahydrothiazolo[4,5-g]quinolines and use as prolactin secretion inhibitors |
| SU1421258A3 (ru) * | 1984-08-02 | 1988-08-30 | Эли Лилли Энд Компани (Фирма) | Способ получени транс-октагидрооксазоло(4,5 @ )хинолина или его фармацевтически приемлемых солей |
| US4537965A (en) * | 1984-08-03 | 1985-08-27 | Eli Lilly And Company | Method of preparing 4aR,8aR-5-permissibly substituted-6-oxo-octahydro-1H(and 2H)-pyrazolo[3,4-g]quinolines, useful as intermediates |
| US4659832A (en) * | 1985-06-10 | 1987-04-21 | Eli Lilly And Company | Process for the preparation of octahydro-oxazolo [4,5-G]quinolines |
-
1986
- 1986-06-16 US US06/874,741 patent/US4826986A/en not_active Expired - Fee Related
-
1987
- 1987-06-09 ZA ZA874137A patent/ZA874137B/xx unknown
- 1987-06-10 NZ NZ220650A patent/NZ220650A/xx unknown
- 1987-06-10 CA CA000539290A patent/CA1307526C/en not_active Expired - Lifetime
- 1987-06-11 PH PH35394A patent/PH25132A/en unknown
- 1987-06-11 MX MX688787A patent/MX6887A/es unknown
- 1987-06-11 PT PT85061A patent/PT85061B/pt not_active IP Right Cessation
- 1987-06-12 EP EP87305240A patent/EP0250179A3/en not_active Withdrawn
- 1987-06-12 DK DK299787A patent/DK299787A/da not_active Application Discontinuation
- 1987-06-15 SU SU874202773A patent/SU1644718A3/ru active
- 1987-06-15 AU AU74229/87A patent/AU597073B2/en not_active Ceased
- 1987-06-15 HU HU872708A patent/HU197900B/hu not_active IP Right Cessation
- 1987-06-16 KR KR1019870006071A patent/KR890005302B1/ko not_active IP Right Cessation
- 1987-06-16 JP JP62150070A patent/JPS62298589A/ja active Pending
- 1987-06-16 CN CN87104651A patent/CN1016872B/zh not_active Expired
- 1987-10-08 AT AT0263287A patent/AT390061B/de not_active IP Right Cessation
Also Published As
| Publication number | Publication date |
|---|---|
| ZA874137B (en) | 1989-01-25 |
| EP0250179A3 (en) | 1989-08-23 |
| JPS62298589A (ja) | 1987-12-25 |
| NZ220650A (en) | 1989-11-28 |
| DK299787A (da) | 1987-12-17 |
| HUT44546A (en) | 1988-03-28 |
| DK299787D0 (da) | 1987-06-12 |
| KR890005302B1 (ko) | 1989-12-20 |
| CN87104651A (zh) | 1988-01-13 |
| US4826986A (en) | 1989-05-02 |
| AU597073B2 (en) | 1990-05-24 |
| HU197900B (en) | 1989-06-28 |
| KR880000430A (ko) | 1988-03-25 |
| PT85061B (pt) | 1990-03-30 |
| AT390061B (de) | 1990-03-12 |
| SU1644718A3 (ru) | 1991-04-23 |
| ATA263287A (de) | 1989-08-15 |
| AU7422987A (en) | 1987-12-17 |
| CN1016872B (zh) | 1992-06-03 |
| EP0250179A2 (en) | 1987-12-23 |
| CA1307526C (en) | 1992-09-15 |
| PH25132A (en) | 1991-02-19 |
| PT85061A (en) | 1987-07-01 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ES539486A0 (es) | Procedimiento para la preparacion de compuestos cotelomeros | |
| ES553138A0 (es) | Procedimiento para la preparacion de 3-ariluracilos | |
| ES551625A0 (es) | Procedimiento para la preparacion de 13-alquil-ll b -fenil-gonamos | |
| MX7769A (es) | Procedimiento para la preparacion de derivados de pirimidina. | |
| MX162864B (es) | Procedimiento para la preparacion de 2,2,6,6-tetraalquil-4-piperidilaminas | |
| ES2017956B3 (es) | Procedimiento para preparar derivados de 4-acetoxi-3-hidroxietilazetidin-2-ona. | |
| ES546484A0 (es) | Procedimiento para la preparacion de derivados de furazano | |
| ES539822A0 (es) | Procedimiento para la preparacion de pirazolopiridinas. | |
| MX6887A (es) | Procedimiento para la preparacion de compuestos analogos de ergolina. | |
| ES555434A0 (es) | Procedimiento para la preparacion de benzoil-ureas | |
| ES554022A0 (es) | Procedimiento para la preparacion de silibinina extenta de isosilibina | |
| MX164891B (es) | Procedimiento para la preparacion de derivados de ergolina | |
| MX17041A (es) | Procedimiento para la preparacion de benzopirano pirazoles. | |
| ES546908A0 (es) | Procedimiento para la preparacion de derivados de fenilace- tonitrilo | |
| MX11650A (es) | Procedimiento para la preparacion de compuestos denaftil-azo-pirazolona | |
| ES2023165B3 (es) | Procedimiento para la preparacion de t-alquil-taralquilperoxidos. | |
| MX15050A (es) | Procedimiento para la preparacion de derivados de 1-arilsulfinil-2-pirrolidinona. | |
| ES2018532B3 (es) | Procedimiento para la preparacion de compuestos carbonilicos. | |
| ES2017485B3 (es) | Proceso para la preparacion de alfa-n-(hipoxantin-9il)pentiloxi-carbonil-arginina. | |
| ES556590A0 (es) | Procedimiento para la obtencion de derivados de piridazo(1,2-a)(1,2)diacepina | |
| MX12003A (es) | Procedimiento para la preparacion de composicionesherbicidas. | |
| MX5413A (es) | Procedimiento para la preparacion de n-benzoil-n'-fenilureas. | |
| ES555457A0 (es) | Procedimiento para la preparacion de derivados de triazolilquinolina | |
| ES549380A0 (es) | Procedimiento para la preparacion de derivados de piperacina | |
| ES549163A0 (es) | Procedimiento para la preparacion de la 1-cinamil-4- benzi- drilpiperazina |